1. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006; 367: 346–355.
2. Roberto Casale M.D a, Alberto Rainoldi Ph. D. Fatigue and fibromyalgia syndrome: Clinical and neurophysiologic pattern. Best Practice & Research Clinical Rheumatology. Volume 25, Issue 2, April 2011, Pages 241–247.
3. Jens D Rollnik. Chronic Fatigue Syndrome: A Critical Review. Fortschr Neurol Psychiatr. 2017 Feb; 85 (2):79–85.
4. Alison C. Bested and Lynn M. Marshall. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. De Gruyter November 27, 2015.
5. Carolina X Sandler, Andrew R Lloyd. Chronic fatigue syndrome: progress and possibilities. The Medical Journal of Australia. 05 April 2020.
6. Deumer US, Varesi A, Floris V, Savioli G, Mantovani E, López-Carrasco P, Rosati GM, Prasad S, Ricevuti G. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview. J Clin Med. 2021 Oct 19; 10 (20):4786.
7. E. Smith et al. Building a measure of fatigue: the functional assessment of chronic illness therapy fatigue scale. Pravara Medical Review. 2010.
8. Bennett BK, Goldstein D, Chen M, et al. Characterization of fatigue states in medicine and psychiatry by structured interview. Psychosom Med 2014; 76: 379–388.
9. Griffith JP, Zarrouf FA. A systematic review of chronic fatigue syndrome: don’t assume it’s depression. Prim Care Companion J Clin Psychiatry 2008; 10: 120–128.
10. Jackson ML, Bruck D. Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review. J Clin Sleep Med 2012; 8: 719–728.
11. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 333: 575.
12. Susanne Macher, Cornelia Herster. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT. Nutrients. 2020 May 5;12 (5):1313.
13. Elizabeth M Maloney, Roumiana S Boneva, Jin-Mann S Lin, William C Reeves. Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia. Metabolism. 2010 Sep; 59 (9):1351–7.
14. D. H. Morris, F. J. Stare. Unproven diet therapies in the treatment of the chronic fatigue syndrome. Arch Fam Med. 1993 Feb; 2 (2):181–6.
15. Kathryn Jones, Yasmine Probst. Role of dietary modification in alleviating chronic fatigue syndrome symptoms: a systematic review. Aust N Z J Public Health. 2017 Aug; 41 (4):338–344.
16. Esme Fuller-Thomson, Jodie Nimigon. Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey. Fam Pract. 2008 Dec; 25 (6):414–22.
17. Grinde B. Viruses belonging to Anelloviridae or Circoviridae as a possible cause of chronic fatigue. J Transl Med. 2020 Dec 14;18 (1):485.
18. Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. 2009 Feb; 8 (4):287–91.
19. Bjørklund G, Dadar M, Pen JJ, Chirumbolo S, Aaseth J. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach. Biomed Pharmacother. 2019 Jan; 109:1000–1007.
20. Allen D, Wainwright M, Hutchinson T. ‘Non-compliance’ as illness management: Hemodialysis patients’ descriptions of adversarial patient-clinician interactions. Soc Sci Med. 2011 Jul; 73(1):129–34.
21. Bautovich A1, Katz I2, Smith M3, Loo CK4, Harvey SB4. Depression and chronic kidney disease: A review for clinicians. Aust N Z J Psychiatry. 2014 Mar 21; 48 (6):530–541.
22. Beddhu S, Bruns FJ., Saul M. et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000, 108:609–613.
23. Bellinghieri G., Santoroi D., Mallamace A. et’al. Sexual dysfunction in chronic renal failure. Nephrology 2008, 21:113–118.
24. Bowling A. Measuring Health: a review of quality of life measurement scales / A. Bowling. – 2nd ed. – Philadelphia: Open University Press, 1997. – 160 p.
25. Charlson ME., Pompei P., Ales KL. et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40: 373–383.
26. Christensen AJ., Wiebe JS., Lawton WJ. Cynical hostility, powerful others control expectancies, and patient adherence in hemodialysis. Psychosom Med, 1997 May, 59:3, 307–12.
27. Depasquale C, Pistorio ML, Corona D, Mistretta A, Zerbo D, Sinagra N, Giaquinta A, Tallarita T, Esker B, Mociskyte D, Leonardi A, Gula R, Veroux P, Veroux M. Correlational study between psychic symptoms and quality of life among hemodialysis patients older than 55 years of age. Transplant Proc. 2012 Sep; 44 (7):1876–8.
28. Ding F, Ahrenholz P, Winkler E et al. Online hemodiafiltration versus acetate-free biofiltration: A prospective crossover study. Artificial Organs 2002, 26:169–180.
29. Donauer J, Schweiger C, Rumberger B, et al. Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis. Nephrol Dial Transplant 2003, 18(8):1616–22.
30. Eisenberg L. A very British kind of social psychiatry / L. Eisenberg // Brit. J. Psychiatry. – 1977. – Vol. 171. – P. 309–313.
31. Feroze U1, Martin D, Kalantar-Zadeh K, Kim JC, Reina-Patton A, Kopple JD. Anxiety and depression in maintenance dialysis patients: preliminary data of a cross-sectional study and brief literature review. J Ren Nutr. 2012 Jan; 22 (1): 207–10.
32. Fried L, Bernardini/, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001, 37: 337–342.
33. García-Llana H1, Remor E, Selgas R. Psicothema. Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis. 2013 Feb; 25 (1):79–86.
34. Hachinski V. C. Multiinfarct dementia. A case of mental deterioration in the elderly / V. C. Hachinski, N. A. Lassen, J. Marshall //Lancet. – 1974. – Vol. 2. – P. 207–210.
35. Hemmelgarn BR, Manns BJV Quan H. et al. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 2003, 42: 125–132.
36. Jain N., Trivedi M. H., Rush A. J. et al. Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). Contemp Clin Trials. 2012; 34 (1):136–144.
37. Jassal S. K., Kritz-Silverstein D., Barrett-Connor E. A Prospective Study of Albuminuria and Cognitive Function in Older Adults. Am. J. Epidemiol. 2010; 171 (3): 277–286.
38. Jin J, Sklar G, Li SC. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag 2008; 4:269–86.
39. Katz S. The index of ADL: a standardized measure of biological and psychological function / S. Katz, A. Ford, R. Moskowitz // Journal of the American Medical Association. – 1963. – Vol. 185. – P. 914–919.
40. Kimmel PL., Peterson RA., Weihs KL., Simmens SJ. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998 Jul, 54 (1):245–54
41. Leggat JE Jr., Orzol SM., Hulbert., Shearon TE et al. Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis, 1998 Jul, 32:1, 139–45
42. Lennihan L. Social concerns and discharge planning / L. Lennihan // Handbook of Neurorehabilitation / ed. by D. C. Good, J. R. Couch, Jr. – New York: Marcel Dekker, Inc., 1994. – P. 165–177.
43. Leplege A. The problem of quality of life in medicine / A. Leplege, S. Hunt // JAMA. – 1997. – Vol. 278. – P. 47–50.
44. Maduell F, Navarro V, Rius A et al. Improvement of nutritional status in patients with short daily on-line hemodiafiltration. Nefrologia 2004, 24:60–66.
45. Mauri. M. Effects of psychopathological components of the onset of Alzheimer’s disease / M. Mauri, S. Bravin, L. Fabiano, G. Invernizzi // Minerva Psychiatrica. – 1995. – Vol. 36. – № 4. – P. 200–207.
46. Mawar S, Gupta S, Mahajan S. Non-compliance to the continuous ambulatory peritoneal dialysis procedure increases the risk of peritonitis. Int Urol Nephrol. 2012 Aug; 44(4): 1243–9.
47. Oyekçin DG, Gülpek D, Sahin EM, Mete L. Depression, anxiety, body image, sexual functioning, and dyadic adjustment associated with dialysis type in chronic renal failure. Int J Psychiatry Med. 2012; 43(3):227–41.
48. Pang SK., Ip WY., Chang AM. Psychosocial correlates of fluid compliance among Chinese haemodialysis patients. J Adv Nurs 2001 Sep., 35 (5):691–8.
49. Pang SK., Ip WY., Chang AM. Psychosocial correlates of fluid compliance among Chinese haemodialysis patients. J Adv Nurs 2001 Sep., 35 (5):691–8.
50. Pereira AA, Sarnak MJ. Anemia as a risk factor for cardiovascular disease. Kidney Int 2003, 64 (S87): S32–S39.
51. Roman G. Senile Dementia of the Binswanger Type / G. Roman // JAMA. – 1987. – Vol. 258, N13. – P. 1782–1788.
52. Аведисова А. С. От нон-комплаенса к отказу от психофармакотерапии. Психиатр и психофармакотер. 2005; 6: 316–8.
53. Айвазян Т. А. Качество жизни больных гипертонической болезнью / Т. А. Айвазян, В. П. Зайцев // Кардиология. – 1999. – № 9. – С. 43–46.
54. Аронов Д. М. Методика оценки качества жизни больных с сердечно-сосудистыми заболеваниями / Д. М. Аронов, В. П. Зайцев // Кардиология. – 2002. – № 5. – С. 92–95.
55. Ахмадеева Л. Р. Тревожность и агрессивность у пациентов, перенесших инсульты / Л. Р. Ахмадеева, Т. М. Абдрашитов, Е. Е. Липатова, Д. Х. Афзалетдинова // Современные диагностические технологии в неврологии: материалы Республ. науч. – практ. конф., посвященной 80-летию проф. Н. А. Борисовой. – Башкортостан, Уфа, 2004. – С. 17–19.